Results 51 to 60 of about 180 (132)
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton +4 more
wiley +1 more source
Медицинский совет, 2019 The article exemplified the successful experience of using combination therapy consisting of fosinopril, an angiotensin-converting enzyme inhibitor, and diltiazem, a non-dihydropyridine calcium antagonist, in a patient with a history of arterial ...
O. D. Ostroumova, I. V. Goloborodova
doaj +1 more source
Fosinopril – a drug of choice in chronic heart failure prevention and treatment
Кардиоваскулярная терапия и профилактика, 2006 Aim. To study ACE inhibitor fosinopril effects on remodeling, diastolic filling of left and right ventricles (LV, RV), ectopic myocardial activity, heart rate variability, endothelial function, and microcirculation in patients with arterial hypertension (
N. Yu. Khosyainova +3 more
doaj
Медицинский совет, 2013 One of the major challenges in the modern medicine is chronic heart failure (CHF) characterized by high incidence, really unfavourable prognosis and high cost of treatment.
G. N. Gorokhovskaya +2 more
doaj +1 more source
THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION
Медицинский совет, 2017 Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time, arterial hypertension (AH) is one of the most common CV pathologies, which, according to foreign researchers, affects about 30–45% of the general ...
S. A. Berns, R. I. Stryuk
doaj +1 more source
CURRENT PROSPECTS FOR THE TREATMENT OF DIABETES COMPLICATIONS
Медицинский совет, 2016 Arterial hypertension (AH) complicates the course of diabetes mellitus (DM) of both the 1st and 2nd type. In patients with diabetes type 1, the main cause of AH is diabetic nephropathy.
M. Y. OGARKOV, Y. V. KOVALEVA
doaj +1 more source
Selection of an ACE inhibitor in clinical practice
Медицинский совет, 2014 Currently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class ...
OD Ostroumova +3 more
doaj +1 more source
Therapeutic effects of fosinopril - ACE inhibitor
КардиоСоматика, 2015 The review article dials with the characteristics of fosinopriltherapeutic features, apparently associated with the fact that it contains phosphorus. It has special specter possessing the numerous of organotropic effects and good tolerability and safety,
D. M Aronov
doaj
Myocarditis as a cause of chronic heart failure
Медицинский совет, 2018 The article is devoted to the diagnosis and management of patients with myocarditis, and its role in the development of chronic heart failure (CHF). It also determined the role of specific therapy and approaches to the treatment of CHF in patients with ...
E. V. Filippov
doaj +1 more source
Кардиоваскулярная терапия и профилактика, 2006 Aim. To study effectiveness of ACE inhibitor therapy in coronary heart disease (CHD) combined with chronic obstructive pulmonary disease (COPD). Material and methods. In total, 89 males with CHD and COPD were examined.
M. A. Popova, N. N. Terentyeva
doaj